{Reference Type}: Journal Article
{Title}: Celebrating a breakthrough: FDA endorses encorafenib plus binimetinib alongside two companion diagnostics for BRAV600E mutant metastatic non-small cell lung cancer.
{Author}: Abbasi HQ;Oduoye MO;Goyal A;
{Journal}: Int J Surg
{Volume}: 110
{Issue}: 4
{Year}: 2024 Apr 1
{Factor}: 13.4
{DOI}: 10.1097/JS9.0000000000001044